ZVRA ZEVRA THERAPEUTICS, INC.
Nasdaq · SEC CIK 1434647 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $2.51M 13 sales by 6 insiders
- Filings on record
- 133 since 2021-08-24, latest 2026-08-17 16:32
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| McFarlane Neil F. | Pres, CEO, Dir | — | $1.19M |
| Thompson Rahsaan | Chief Legal, Compliance, Sec | — | $969.4K |
| Watton Corey Michael | Dir | — | $138.4K |
| Schafer Joshua | CCO | — | $126.3K |
| Sangiovanni Timothy J. | SVP, Fin, Corp Ctrl | — | $43.0K |
| Quartel Adrian W | Chief Medical Off | — | $40.0K |
| Bode John B | Dir | — | — |
| Clifton R. LaDuane | Former CFO, Treas | — | — |
Transactions 82
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-17 16:32 | 2026-08-14 | ZVRA | Thompson Rahsaan | Chief Legal, Compliance | S - Sale | $11.13 | -42.7K | 37.6K | -53% | -$474.8K |
| D | 2026-08-12 16:16 | 2026-08-10 | ZVRA | Watton Corey Michael | Dir | M - OptEx | $4.97 | +12.3K | 14.1K | +683% | +$61.1K |
| D | 2026-08-12 16:16 | 2026-08-10 | ZVRA | Watton Corey Michael | Dir | S - Sale+OE | $11.25 | -12.3K | 1,800 | -87% | -$138.4K |
| DT | 2026-06-23 16:16 | 2026-06-21 | ZVRA | Thompson Rahsaan | Chief Legal, Compliance | M - OptEx | — | +66.7K | 114.8K | +139% | — |
| DT | 2026-06-23 16:16 | 2026-06-22 | ZVRA | Thompson Rahsaan | Chief Legal, Compliance | S - Sale+OE | $12.68 | -34.6K | 80.2K | -30% | -$438.3K |
| T | 2026-05-13 16:32 | 2026-05-11 | ZVRA | Thompson Rahsaan | Chief Legal, Compliance | S - Sale | $11.30 | -1,794 | 48.1K | -4% | -$20.3K |
| DM | 2026-03-26 | 2026-03-24 | ZVRA | Bode John B | Dir | M - OptEx | $4.93 | +78.4K | 123.4K | +174% | +$386.5K |
| D | 2026-02-10 | 2026-02-09 | ZVRA | McFarlane Neil F. | Pres, CEO, Dir | S - Sale+OE | $8.56 | -14.6K | 387.2K | -4% | -$125.2K |
| D | 2026-02-10 | 2026-02-07 | ZVRA | McFarlane Neil F. | Pres, CEO, Dir | M - OptEx | — | +37.5K | 401.9K | +10% | — |
| 2026-02-04 | 2026-02-03 | ZVRA | Schafer Joshua | CCO | S - Sale | $9.19 | -10.5K | 62.3K | -14% | -$96.5K | |
| 2026-02-04 | 2026-02-03 | ZVRA | Sangiovanni Timothy J. | SVP, Fin, Corp Ctrl | S - Sale | $9.18 | -3,000 | 29.6K | -9% | -$27.5K | |
| D | 2026-02-02 | 2026-01-30 | ZVRA | Quartel Adrian W | Chief Medical Off | S - Sale+OE | $8.83 | -4,533 | 9,723 | -32% | -$40.0K |
| D | 2026-02-02 | 2026-01-30 | ZVRA | Quartel Adrian W | Chief Medical Off | M - OptEx | — | +11.3K | 14.3K | +388% | — |
| D | 2026-02-02 | 2026-01-30 | ZVRA | Sangiovanni Timothy J. | SVP, Fin, Corp Ctrl | S - Sale+OE | $8.82 | -1,750 | 20.9K | -8% | -$15.4K |
| DM | 2026-02-02 | 2026-01-30+ | ZVRA | Sangiovanni Timothy J. | SVP, Fin, Corp Ctrl | M - OptEx | — | +18.0K | 22.7K | +385% | — |
| D | 2026-02-02 | 2026-02-02 | ZVRA | McFarlane Neil F. | Pres, CEO, Dir | S - Sale+OE | $9.38 | -91.0K | 364.4K | -20% | -$853.6K |
| D | 2026-02-02 | 2026-01-31 | ZVRA | McFarlane Neil F. | Pres, CEO, Dir | M - OptEx | — | +233.3K | 455.4K | +105% | — |
| D | 2026-02-02 | 2026-01-30 | ZVRA | Thompson Rahsaan | Chief Legal, Compliance, Sec | S - Sale+OE | $8.83 | -4,080 | 49.9K | -8% | -$36.0K |
| D | 2026-02-02 | 2026-01-30 | ZVRA | Thompson Rahsaan | Chief Legal, Compliance, Sec | M - OptEx | — | +11.3K | 54.0K | +27% | — |
| DM | 2026-02-02 | 2026-01-30+ | ZVRA | Schafer Joshua | CCO | M - OptEx | — | +46.7K | 72.8K | +179% | — |
| D | 2026-02-02 | 2026-01-30 | ZVRA | Schafer Joshua | CCO | S - Sale+OE | $8.83 | -3,375 | 37.4K | -8% | -$29.8K |
| D | 2026-01-07 | 2025-12-31 | ZVRA | Clifton R. LaDuane | Former CFO, Treas | F - Tax | $8.96 | -48.5K | 143.5K | -25% | -$434.7K |
| D | 2026-01-07 | 2025-12-31 | ZVRA | Clifton R. LaDuane | Former CFO, Treas | M - OptEx | $0.00 | +140.7K | 192.0K | +274% | $0 |
| D | 2025-10-10 | 2025-10-10 | ZVRA | McFarlane Neil F. | Pres, CEO, Dir | M - OptEx | — | +50.0K | 241.5K | +26% | — |
| D | 2025-10-10 | 2025-10-10 | ZVRA | McFarlane Neil F. | Pres, CEO, Dir | S - Sale+OE | $10.82 | -19.5K | 222.0K | -8% | -$211.0K |
| 2025-09-16 | 2025-09-12 | ZVRA | FAVORITO TAMARA A | Dir | P - Purchase | $7.79 | +3,175 | 3,894 | +442% | +$24.7K | |
| 2025-09-15 | 2025-09-12 | ZVRA | Shih Alvin | Dir | P - Purchase | $7.89 | +20.0K | 20.0K | New | +$157.8K | |
| 2025-08-20 | 2025-08-19 | ZVRA | Bode John B | Dir | P - Purchase | $9.17 | +5,000 | 45.0K | +12% | +$45.9K | |
| 2025-06-30 | 2025-06-26 | ZVRA | Thompson Rahsaan | Chief Legal, Compliance, Sec | S - Sale | $9.21 | -24.0K | 42.7K | -36% | -$221.0K | |
| D | 2025-06-24 | 2025-06-21 | ZVRA | Thompson Rahsaan | Chief Legal, Compliance, Sec | M - OptEx | — | +66.7K | 66.7K | New | — |
| 2025-03-31 | 2025-03-28 | ZVRA | Watton Corey Michael | Dir | P - Purchase | $7.84 | +300 | 1,800 | +20% | +$2,352 | |
| 2025-03-21 | 2025-03-19 | ZVRA | Bode John B | Dir | P - Purchase | $7.96 | +10.0K | 40.0K | +33% | +$79.6K | |
| 2025-02-14 | 2025-02-13 | ZVRA | Sangiovanni Timothy J. | SVP, Fin, Corp Ctrl | S - Sale | $7.86 | -3,000 | 16.3K | -16% | -$23.6K | |
| 2025-02-14 | 2025-02-13 | ZVRA | Schafer Joshua | CCO, EVP, Bus. Development | S - Sale | $7.86 | -10.5K | 29.5K | -26% | -$82.5K | |
| 2025-02-14 | 2025-02-13 | ZVRA | Clifton R. LaDuane | CFO, Treas | S - Sale | $7.86 | -11.0K | 51.4K | -18% | -$86.5K | |
| M | 2025-02-14 | 2025-02-13+ | ZVRA | McFarlane Neil F. | Pres, CEO, Dir | S - Sale | $7.92 | -91.8K | 222.1K | -29% | -$727.5K |
| D | 2025-02-03 | 2025-01-31 | ZVRA | Sangiovanni Timothy J. | SVP, Fin, Corp Ctrl | M - OptEx | — | +11.7K | 19.3K | +152% | — |
| D | 2025-02-03 | 2025-01-31 | ZVRA | McFarlane Neil F. | Pres, CEO, Dir | M - OptEx | — | +233.3K | 283.3K | +467% | — |
| D | 2025-02-03 | 2025-01-31 | ZVRA | Clifton R. LaDuane | CFO, Treas | M - OptEx | — | +43.3K | 62.4K | +228% | — |
| D | 2025-02-03 | 2025-01-31 | ZVRA | Schafer Joshua | CCO, EVP, Bus. Development | M - OptEx | — | +35.3K | 40.0K | +759% | — |
| 2024-10-16 | 2024-10-11 | ZVRA | Watton Corey Michael | Dir | P - Purchase | $7.92 | +500 | 1,500 | +50% | +$3,960 | |
| 2024-07-17 | 2024-07-17 | ZVRA | Clifton R. LaDuane | CFO, Treas | P - Purchase | $6.77 | +2,000 | 18.5K | +12% | +$13.5K | |
| 2024-07-16 | 2024-07-16 | ZVRA | Anderson Thomas | Dir | P - Purchase | $6.81 | +10.0K | 20.0K | +100% | +$68.1K | |
| 2024-07-15 | 2024-07-12 | ZVRA | Bode John B | Dir | P - Purchase | $5.87 | +10.0K | 30.0K | +50% | +$58.7K | |
| 2023-09-06 | 2023-09-05 | ZVRA | Bode John B | Dir | P - Purchase | $5.13 | +10.0K | 20.0K | +100% | +$51.3K | |
| 2023-09-06 | 2023-09-06 | ZVRA | Anderson Thomas | Dir | P - Purchase | $4.88 | +10.0K | 10.0K | New | +$48.8K | |
| 2023-09-06 | 2023-09-05 | ZVRA | Schafer Joshua | CCO, EVP, Bus. Development | P - Purchase | $5.13 | +500 | 3,500 | +17% | +$2,565 | |
| 2023-09-06 | 2023-09-06 | ZVRA | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $4.96 | +1,000 | 15.3K | +7% | +$4,960 | |
| 2023-06-30 | 2023-05-19 | ZVRA | Schafer Joshua | CCO, EVP, Bus. Development | P - Purchase | $5.42 | +1,000 | 3,000 | +50% | +$5,420 | |
| 2023-06-26 | 2023-06-23 | ZVRA | Watton Corey Michael | Dir | P - Purchase | $5.95 | +275 | 1,000 | +38% | +$1,636 | |
| 2023-06-13 | 2023-06-09 | ZVRA | Watton Corey Michael | Dir | P - Purchase | $5.52 | +325 | 725 | +81% | +$1,794 | |
| 2023-05-31 | 2023-05-30 | ZVRA | Watton Corey Michael | Dir | P - Purchase | $5.11 | +400 | 400 | New | +$2,044 | |
| M | 2023-05-19 | 2023-05-18 | ZVRA | Bode John B | Dir | P - Purchase | $5.04 | +10.0K | 10.0K | New | +$50.4K |
| M | 2023-05-18 | 2023-05-18 | ZVRA | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $4.95 | +2,740 | 13.7K | +25% | +$13.6K |
| 2023-03-21 | 2023-03-17 | ZVRA | SEYMOUR TAMARA A | Dir | P - Purchase | $4.82 | +519 | 719 | +260% | +$2,502 | |
| 2023-03-15 | 2023-03-14 | ZVRA | Schafer Joshua | CCO, EVP, Bus. Development | P - Purchase | $4.61 | +2,000 | 2,000 | New | +$9,220 | |
| 2023-03-13 | 2023-03-10 | ZVRA | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $4.15 | +1,725 | 11.0K | +19% | +$7,159 | |
| 2023-03-13 | 2023-03-09 | ZVRA | Tierney David S | Dir | P - Purchase | $4.15 | +5,000 | 10.8K | +86% | +$20.8K | |
| 2023-03-13 | 2023-03-09 | ZVRA | Plooster Matthew R | Dir | P - Purchase | $4.20 | +11.0K | 18.5K | +147% | +$46.2K | |
| 2023-03-13 | 2023-03-09 | ZVRA | Pascoe Richard W | CEO, Dir | P - Purchase | $4.20 | +10.0K | 30.0K | +50% | +$42.0K | |
| M | 2023-03-13 | 2023-03-10 | ZVRA | Sangiovanni Timothy J. | SVP, Corp. Ctrl | P - Purchase | $4.14 | +1,200 | 4,449 | +37% | +$4,968 |
| 2023-01-13 | 2023-01-13 | ZVRA | Pascoe Richard W | CEO, Dir | P - Purchase | $5.44 | +9,500 | 20.0K | +91% | +$51.7K | |
| M | 2023-01-13 | 2023-01-13 | ZVRA | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $5.81 | +635 | 9,277 | +7% | +$3,690 |
| M | 2022-10-03 | 2022-09-30 | ZVRA | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $5.98 | +1,000 | 7,709 | +15% | +$5,980 |
| 2022-05-26 | 2022-05-25 | ZVRA | Tierney David S | Dir | P - Purchase | $4.39 | +2,000 | 5,835 | +52% | +$8,780 | |
| M | 2022-05-25 | 2022-05-25 | ZVRA | Mickle Travis C | Pres, CEO, Dir | P - Purchase | $4.37 | +3,000 | 38.5K | +8% | +$13.1K |
| I | 2022-05-25 | 2022-05-25 | ZVRA | Mickle Travis C | Pres, CEO, Dir | P - Purchase | $4.39 | +10.0K | 11.0K | +967% | +$43.9K |
| 2022-05-24 | 2022-05-20 | ZVRA | SEYMOUR TAMARA A | Dir | P - Purchase | $4.87 | +200 | 200 | New | +$974 | |
| M | 2022-05-18 | 2022-05-18 | ZVRA | Pascoe Richard W | Executive COB, Dir | P - Purchase | $4.92 | +5,000 | 8,285 | +152% | +$24.6K |
| 2022-05-18 | 2022-05-18 | ZVRA | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $5.00 | +1,200 | 6,440 | +23% | +$6,000 | |
| M | 2022-05-18 | 2022-05-18 | ZVRA | Plooster Matthew R | Dir | P - Purchase | $4.96 | +5,000 | 7,161 | +231% | +$24.8K |
| 2021-12-01 | 2021-12-01 | ZVRA | Plooster Matthew R | Dir | A - Grant | $8.44 | +2,500 | 2,500 | New | +$21.1K | |
| 2021-11-30 | 2021-11-30 | ZVRA | Tierney David S | Dir | P - Purchase | $7.79 | +2,000 | 3,835 | +109% | +$15.6K | |
| 2021-11-30 | 2021-11-30 | ZVRA | Pascoe Richard W | Executive COB, Dir | P - Purchase | $7.88 | +1,500 | 3,285 | +84% | +$11.8K | |
| 2021-11-23 | 2021-11-18 | ZVRA | Mickle Travis C | Pres, CEO, Dir | P - Purchase | $8.23 | +2,250 | 36.5K | +7% | +$18.5K | |
| 2021-11-18 | 2021-11-18 | ZVRA | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $8.29 | +510 | 5,240 | +11% | +$4,228 | |
| 2021-09-29 | 2021-09-29 | ZVRA | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $9.38 | +215 | 4,730 | +5% | +$2,017 | |
| 2021-09-20 | 2021-09-20 | ZVRA | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $8.59 | +935 | 4,515 | +26% | +$8,032 | |
| 2021-09-01 | 2021-09-01 | ZVRA | Clifton R. LaDuane | CFO, Sec, Treas | P - Purchase | $9.11 | +230 | 3,580 | +7% | +$2,095 | |
| 2021-08-30 | 2021-08-30 | ZVRA | Mickle Travis C | Pres, CEO, Dir | P - Purchase | $8.92 | +5,000 | 34.3K | +17% | +$44.6K | |
| DM | 2021-08-24 | 2021-08-24 | ZVRA | Mickle Travis C | Pres, CEO, Dir | J - Other | $0.00 | -96.5K | 0 | -100% | $0 |
| DMI | 2021-08-24 | 2021-08-24 | ZVRA | Mickle Travis C | Pres, CEO, Dir | J - Other | $0.00 | +87.1K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations